219 related articles for article (PubMed ID: 8027925)
21. Effect of hydroxypropyl-beta-cyclodextrin on the solubility of an antibacterial isoxazolyl-naphthoquinone.
Linares MS; de Bertorello MM; Longhi MR
Drug Dev Ind Pharm; 2000 Sep; 26(9):1003-6. PubMed ID: 10914326
[TBL] [Abstract][Full Text] [Related]
22. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
23. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
Arima H; Adachi H; Irie T; Uekama K; Pitha J
Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
[TBL] [Abstract][Full Text] [Related]
25. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
26. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
[TBL] [Abstract][Full Text] [Related]
27. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
28. Allylthiosulfinate: beta-cyclodextrin inclusion complex: preparation, characterization and microbiological activity.
Nikolic V; Stankovic M; Kapor A; Nikolic Lj; Cvetkovic D; Stamenković J
Pharmazie; 2004 Nov; 59(11):845-8. PubMed ID: 15587584
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse.
Brewster ME; Anderson WR; Loftsson T; Huang MJ; Bodor N; Pop E
J Pharm Sci; 1995 Oct; 84(10):1154-9. PubMed ID: 8801327
[TBL] [Abstract][Full Text] [Related]
30. In vitro comparison of the antimycotic activity of a miconazole-HP-beta-cyclodextrin solution with a miconazole surfactant solution.
Piel G; Hayette MP; Pavoni E; Evrard B; Van Hees T; de Hassonville SH; De Mol P; Delattre L
J Antimicrob Chemother; 2001 Jul; 48(1):83-7. PubMed ID: 11418515
[TBL] [Abstract][Full Text] [Related]
31. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
32. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
Irie T; Fukunaga K; Pitha J
J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
[TBL] [Abstract][Full Text] [Related]
33. Effects of preservatives, steroids, and ethylenediaminetetraacetate on the antimicrobial activity of sulfacetamide.
Houlsby RD; Ghajar M; Chavez L
J Pharm Sci; 1983 Dec; 72(12):1401-3. PubMed ID: 6420538
[TBL] [Abstract][Full Text] [Related]
34. Chromatographic determination of the association constants between nimesulide and native and modified beta-cyclodextrins.
Ravelet C; Geze A; Villet A; Grosset C; Ravel A; Wouessidjewe D; Peyrin E
J Pharm Biomed Anal; 2002 Jul; 29(3):425-30. PubMed ID: 12062643
[TBL] [Abstract][Full Text] [Related]
35. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
Lopez RF; Collett JH; Bentley MV
Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694
[TBL] [Abstract][Full Text] [Related]
36. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Chang SL; Banga AK
J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
[TBL] [Abstract][Full Text] [Related]
37. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
[TBL] [Abstract][Full Text] [Related]
38. Development and Evaluation of Antimicrobial and Modulatory Activity of Inclusion Complex of
de Almeida Magalhães TSS; de Oliveira Macedo PC; Kawashima Pacheco SY; Silva SSD; Barbosa EG; Pereira RR; Costa RMR; Silva Junior JOC; da Silva Ferreira MA; de Almeida JC; Rolim Neto PJ; Converti A; Neves de Lima ÁA
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023867
[TBL] [Abstract][Full Text] [Related]
39. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Kimura K; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous interaction of steroidal drugs with gamma- and hydroxypropyl-beta-cyclodextrin studied by charge-transfer chromatography.
Cserháti T; Forgács E
J Pharm Biomed Anal; 2000 Feb; 22(1):25-31. PubMed ID: 10727120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
